UBS Group AG - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 97 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$655,426
-55.6%
206,759
-30.4%
0.00%
Q2 2023$1,476,149
+28.5%
297,012
+27.7%
0.00%
Q1 2023$1,148,604
+34.4%
232,511
+71.1%
0.00%
Q4 2022$854,685
-56.4%
135,880
-25.1%
0.00%
-100.0%
Q3 2022$1,960,000
+25.2%
181,476
+32.2%
0.00%0.0%
Q2 2022$1,565,000
-22.9%
137,269
-38.4%
0.00%0.0%
Q1 2022$2,030,000
-13.8%
222,867
+41.3%
0.00%0.0%
Q4 2021$2,354,000
-46.9%
157,741
-8.6%
0.00%0.0%
Q3 2021$4,434,000
+343.4%
172,510
+349.8%
0.00%
Q2 2021$1,000,000
-67.0%
38,349
-55.3%
0.00%
-100.0%
Q1 2021$3,028,000
+9362.5%
85,758
+6799.3%
0.00%
Q4 2020$32,000
-40.7%
1,243
-13.8%
0.00%
Q3 2020$54,000
-57.8%
1,442
-51.6%
0.00%
Q2 2020$128,000
+106.5%
2,979
-5.5%
0.00%
Q1 2020$62,000
+3.3%
3,153
+35.8%
0.00%
Q4 2019$60,000
-43.9%
2,322
-40.9%
0.00%
Q3 2019$107,000
-93.4%
3,927
-93.5%
0.00%
-100.0%
Q2 2019$1,630,000
+508.2%
60,685
+555.5%
0.00%
Q1 2019$268,000
+230.9%
9,258
+206.4%
0.00%
Q4 2018$81,0003,0220.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders